Literature DB >> 28004026

Flow cytometric data analysis of circulating progenitor cell stability.

Ernestine A Mahar1, Liping Mou1, Salim S Hayek1, Arshed A Quyyumi1, Edmund K Waller1.   

Abstract

A recent publication by Mekonnen et al. demonstrated that among women with non-obstructive coronary artery disease, higher levels of circulating progenitor cells in the blood (CPC), were associated with impaired coronary flow reserve [1]. We performed a quality control assessment of the stability of circulating blood progenitor cells in blood samples stored at 4 °C, to determine the time period during which blood samples can be analyzed and yield consistent data for progenitor cell content. Healthy volunteers (n=6) were recruited and underwent phlebotomy, and blood was stored in EDTA tubes at 4 °C. Flow cytometry was performed to quantitate progenitor cell subsets at 0-4 h, 24 h, and 48 h post phlebotomy. All processed samples were fixed with 1% Paraformaldehyde and 1,000,000 total data events were collected. We found no significant differences in PC data for both CD34+ (P=0.68 for one-way ANOVA) and CD34+/CD133+ (P=0.74 for one-way ANOVA).

Entities:  

Year:  2016        PMID: 28004026      PMCID: PMC5157704          DOI: 10.1016/j.dib.2016.11.050

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data Increased confidence in data from rare progenitors in blood samples stored up to 48 h. Increased opportunities for collaborations with distant institutions up to 48 h shipping samples to a central lab for analysis. Multiple samples collected during one day can be analyzed in a batch the following day, thus increasing the efficiency of laboratory personnel analyzing samples.

Data

Progenitor cell content for CD34+/CD45dim, CD34+/CD133+/CD45dim, subsets in 300 uL aliquots of anticoagulated blood were measured by flow cytometry. Triplicate aliquots of blood from each sample were analyzed at each time point, and the mean values for each time point for every subject were calculated to determine the stability of the progenitor cell content during storage (Fig. 1). The standardized mean values for the 0–4 h time point was used as the baseline, and the relative change of mean values for the subsequent time points was calculated as a percentage of the baseline value. We found no significant differences in PC counts for both CD34+ (Fig. 1 Panel A, P=0.68) and CD34+/CD133+ (Fig. 1 Panel B, P=0.74).
Fig. 1

Stability of progenitor cells over time during storage at 4 °C. A. Percentage change in mean values of CD34+/CD45dim cells from baseline values measured at 0–4 h and after 24 and 48 h storage. B. Percentage change of mean values of CD34+/CD45dim/CD133+ from baseline values measured at 0–4 h and after 24 and 48 h storage.

Experimental design, materials and methods

Gently mix by inversion and reverse pipet 300 ul blood sample to a 5 ml FACS tube. Add antibody cocktail to blood sample and vortex and incubate in the dark for 15 min. Add 1.2 ml Ammonium chloride lysis buffer, vortex and incubate in the dark for 10 min. Sample should become relatively transparent post lysis. Add 1.2 ml staining media the add 350 ul 1% paraformaldehyde to fix cells, seal the tubes with parafilm and mix gently by inverting several times. Store samples at 4 °C. Before acquisition on the FACS Canto II, reverse pipet 100 ul Invitrogen counting beads to the prepared samples, mixed gently and run. FCS files we a’re analyzed in FlowJo version 9.8.5.

Materials

Tris Buffered Ammonium chloride Lysis solution- 2.06 g Tris Hydrochloride. 8.26 g Ammonium chloride. 0.037 g EDTA. QS to 1 L DI H2O and pH to 7.2–7.5 using ammonium Hydroxide. Store at RT. Staining Media- 1X PBS 485 mL. 15 mL FBS. 0.5 g of Sodium azide (NaN3). Combine and store at 4 °C.
Subject areaMedicine
More specific subject areaCardiology
Type of dataTables, graphs
How data was acquiredFlow cytometry on BD FACS Canto II RUO
Data formatAnalyzed
Experimental factorsEDTA preserved samples
Experimental featuresA lyse-no wash procedure with the addition of fluorescent counting beads
Data source locationAtlanta, GA, USA.
Data accessibilityData included in the article
ItemManufacturerCatalog number
CD34Becton Dickson340430
CD133Miltenyi Biotech130-090-826
CD45Becton Dickson348805
AccuCheck Counting beadsFisherPCB100_3654889900
Tris HydrochlorideFisherBP153
Ammonium chlorideSigmaA4514
EDTASigmaED2SS
Ammonium hydroxideSigmaA6899
Phosphate buffered saline (PBS)Corning21–040-CV
Fetal Bovine Serum (FBS)SigmaF4135
Sodium AzideSigmaS8032
ParaformaldehydeFisher04042
  1 in total

1.  Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).

Authors:  Girum Mekonnen; Salim S Hayek; Puja K Mehta; Qunna Li; Ernestine Mahar; Liping Mou; Tanya S Kenkre; John W Petersen; Babak Azarbal; Bruce Samuels; R David Anderson; Tara Sedlak; Melody Zaya; Megha Agarwal; Afsaneh Haftbaradaran; Margo Minissian; Eileen Handberg; Carl J Pepine; Christopher R Cogle; C Noel Bairey Merz; Edmund K Waller; Arshed A Quyyumi
Journal:  Atherosclerosis       Date:  2016-08-26       Impact factor: 6.847

  1 in total
  6 in total

1.  Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study.

Authors:  Zakaria Almuwaqqat; Jeong Hwan Kim; Mariana Garcia; Yi-An Ko; Kasra Moazzami; Bruno Lima; Samaah Sullivan; Jamil Alkhalaf; Anurag Mehta; Amit J Shah; Mohammad S Hussain; Brad D Pearce; J Douglas Bremner; Edmund K Waller; Viola Vaccarino; Arshed A Quyyumi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-09-23       Impact factor: 8.311

2.  Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.

Authors:  Anurag Mehta; Kreton Mavromatis; Yi-An Ko; Steven C Rogers; Devinder S Dhindsa; Cydney Goodwin; Risha Patel; Mohammad A Martini; Mahadev Prasad; Ali Mokhtari; Iraj G Hesaroieh; Stephen C Frohwein; Michael H Kutner; Arash Harzand; Bryan J Wells; Yazan Duwayri; Olamide Alabi; Ravi R Rajani; Luke P Brewster; Edmund K Waller; Arshed A Quyyumi
Journal:  Contemp Clin Trials       Date:  2020-03-04       Impact factor: 2.226

3.  Circulating Progenitor Cells and Racial Differences.

Authors:  Ayman Samman Tahhan; Muhammad Hammadah; Heval Mohamed Kelli; Jeong Hwan Kim; Pratik B Sandesara; Ayman Alkhoder; Belal Kaseer; Mohamad Mazen Gafeer; Matthew Topel; Salim S Hayek; Wesley T O'Neal; Malik Obideen; Yi-An Ko; Chang Liu; Iraj Hesaroieh; Ernestine Mahar; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

4.  Quantitative exploration of factors influencing psychotic disorder ailments in Nigeria.

Authors:  Adebowale O Adejumo; Nehemiah A Ikoba; Esivue A Suleiman; Hilary I Okagbue; Pelumi E Oguntunde; Oluwole A Odetunmibi; Obalowu Job
Journal:  Data Brief       Date:  2017-07-24

5.  Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study.

Authors:  Shabatun J Islam; Jeong Hwan Kim; Matthew Topel; Chang Liu; Yi-An Ko; Mahasin S Mujahid; Mario Sims; Mohamed Mubasher; Kiran Ejaz; Jan Morgan-Billingslea; Kia Jones; Edmund K Waller; Dean Jones; Karan Uppal; Sandra B Dunbar; Priscilla Pemu; Viola Vaccarino; Charles D Searles; Peter Baltrus; Tené T Lewis; Arshed A Quyyumi; Herman Taylor
Journal:  J Am Heart Assoc       Date:  2020-04-28       Impact factor: 5.501

6.  Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency.

Authors:  Anurag Mehta; Ayman S Tahhan; Chang Liu; Devinder S Dhindsa; Aditi Nayak; Ananya Hooda; Kasra Moazzami; Shabatun J Islam; Steven C Rogers; Zakaria Almuwaqqat; Ali Mokhtari; Iraj Hesaroieh; Yi-An Ko; Edmund K Waller; Arshed A Quyyumi
Journal:  JACC Basic Transl Sci       Date:  2020-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.